Johnson & Johnson Assets & Liabilities Overview 2006-2018 | JNJ

Current and historical assets & liabilities overview for Johnson & Johnson (JNJ) from 2006 to 2018.
Johnson & Johnson Annual Assets & Liabilities Overview
(Millions of US $)
Johnson & Johnson Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $376.840B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $257.521B 15.07
Novartis AG (NVS) Switzerland $196.752B 16.88
Merck (MRK) United States $188.679B 16.66
AbbVie (ABBV) United States $137.829B 13.46
Novo Nordisk (NVO) Denmark $114.846B 18.36
Eli Lilly (LLY) United States $113.563B 21.02
Sanofi (SNY) France $110.105B 13.94
Bristol-Myers Squibb (BMY) United States $99.380B 17.99
GlaxoSmithKline (GSK) United Kingdom $98.081B 13.10
AstraZeneca (AZN) United Kingdom $94.477B 10.39